Randomized, Double-Blind, Phase 3 Trial of Triple Therapy With Dapagliflozin Add-on to Saxagliptin Plus Metformin in Type 2 Diabetes.
Saved in:
| Title: | Randomized, Double-Blind, Phase 3 Trial of Triple Therapy With Dapagliflozin Add-on to Saxagliptin Plus Metformin in Type 2 Diabetes. |
|---|---|
| Authors: | Mathieu C; Katholieke Universiteit Leuven, Leuven, Belgium chantal.mathieu@med.kuleuven.be., Ranetti AE; Carol Davila University of Medicine and Pharmacy, Bucharest, Romania., Li D; Bristol-Myers Squibb, Princeton, NJ., Ekholm E; AstraZeneca, Molndal, Sweden., Cook W; AstraZeneca, Gaithersburg, MD., Hirshberg B; MedImmune, Gaithersburg, MD., Chen H; AstraZeneca, Gaithersburg, MD., Hansen L; Bristol-Myers Squibb, Princeton, NJ., Iqbal N; Bristol-Myers Squibb, Princeton, NJ. |
| Source: | Diabetes care [Diabetes Care] 2015 Nov; Vol. 38 (11), pp. 2009-17. Date of Electronic Publication: 2015 Aug 05. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
